HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Virax Biolabs Group Ltd Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.	United States of America	VRAX
VisionSys AI Inc Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.	United States of America	VSA
Vivesto Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.	Sweden	VIVE
Vor Biopharma Inc. Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.	United States of America	VOR
Voronoi, Inc. Develops selective kinase inhibitors and targeted protein degraders for precision oncology.	South Korea	310210
Voyager Therapeutics, Inc. Developing AAV gene therapies for neurological diseases like Alzheimer's, ALS, and Parkinson's.	United States of America	VYGR
VS MEDIA Holdings Ltd A global media network connecting creators and brands for data-driven social commerce.	United States of America	VSME
WDB coco CO.,LTD. CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.	Japan	7079
WDB HOLDINGS CO.,LTD. Provides specialized staffing, contract research (CRO) services, and related digital platforms.	Japan	2475
WEATHERNEWS INC. Global weather data & risk solutions for B2B (sea, air, land) and consumer apps.	Japan	4825